bioMérieux was proud to present its ninth Award on Pathogen Research at the “Eleventh Conference on Food Microbiology”, held this year by the University of Ghent, Belgium, on September 14th and 15th.
Canada
MNA Rizqy and Minister Fitzgibbon honor the employees of bioMérieux Canada Inc. with the National Assembly Medal for their exceptional contribution during the COVID-19 pandemic
27 June, 2022The bioMérieux Canada team remained true to its commitment towards public health by ensuring the installation of the BIOFIRE® systems in record time. The team traveled across Canada despite the sanitary restrictions to ensure adequate user training and was able to demonstrate agility and innovation...
bioMérieux Award 2006 on Excellence in Pathogen Research
14 September, 2006
bioMérieux confirms its commitment to the fight against the AIDS virus in Africa
01 August, 2006
A major player in in vitro diagnostics specialized in the fight against infectious diseases, bioMérieux confirms its success in the fight against the AIDS virus in Africa.
bioMérieux Sells its Hemostasis Line of Business
27 June, 2006
bioMérieux, a global leader in the field of in vitro diagnostics, today announced the closing of the sale of its hemostasis range of products to Trinity Biotech plc.
bioMérieux contributes to the fight against AIDS in the Democratic Republic of Congo
23 May, 2006
bioMérieux, the world's third-largest diagnostic company in the field of infectious diseases, has won a new contract ; the company will be the exclusive provider of equipment for measuring HIV viral load in the Democratic Republic of Congo.
bioMérieux NucliSENS® easyMAG™ Receives Technology Innovation of the Year Award from Frost & Sullivan
25 April, 2006
2006 Technology Innovation Award of the Year in the field of In Vitro Diagnostics. bioMérieux has been the proud recipient of 2006 Technology Innovation of the Year award in the field of in vitro diagnostics. After extensive evaluation, Frost & Sullivan, an industry-leading global growth consulting company, chose bioMérieux for their development of the NucliSENS easyMAG system. The NucliSENS easyMAG is a breakthrough platform based on the company’s proprietary technologies and features premium nucleic acid extraction quality and enhanced productivity through highly accessible instrumentation.
ExonHit and bioMérieux reach an important research milestone in the molecular detection of breast cancer from blood samples
29 March, 2006
ExonHit Therapeutics, a French drug and diagnostic discovery company, and bioMérieux, a major player in the field of in vitro diagnostics, announce today that they have reached an important research milestone in the diagnosis of breast cancer.
bioMérieux launches an avian flu test for research purposes
02 February, 2006
As a major player in the field of in vitro diagnostics, bioMérieux confirms its commitment to the fight against emerging diseases and launches its avian flu detection test.